E6: Notification/Submission to Regulatory Authority(ies)

Question 1

5.10

Notification/Submission to Regulatory Authority(ies)

Answer 1

Before initiating the clinical trial(s), the sponsor (or the sponsor and the investigator, if required by the applicable regulatory requirement(s)) should submit any required application(s) to the appropriate authority(ies) for review, acceptance, and/or permission (as required by the applicable regulatory requirement(s)) to begin the trial(s). Any notification/submission should be dated and contain sufficient information to identify the protocol.